May 19, 2016

Two-pronged attack on chemotherapy-resistant leukemia cells

All stems from malignant transformed precursor lymphocytes, the blood's defense cells. Nowadays, four out of five young leukemia patients can be treated successfully with aggressive chemotherapy. Source link

Related News
May 27, 2015

Melanoma, pediatric cancer and lymphoma dominate research from NYU Langone at ASCO 2015

Plasma cell disorders and epidemiology studies also play a prominent roleNYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center will have a high profile at the 51st… Read More

March 31, 2015

Experts set strategic priorities for lymphoma research

A committee of lymphoma experts today unveiled a strategic roadmap identifying key priority areas in both infrastructure and research that will be critical for advancing treatments for people with… Source Read More